Certain segments of the biopharmaceutical manufacturing industry are set to make big leaps in capacity over the next five years. Where will that expansion take place? Nope, not in Asia. Europe's the big beneficiary here. Report
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Comments